Toxin B is essential for virulence of Clostridium difficile

Nature

Volumn 458, Issue 7242, 2009, Pages 1176-1179

  Lyras, Dena ^a   O'Connor, Jennifer R ^a,b,c   Howarth, Pauline M ^a   Sambol, Susan P ^b,c   Carter, Glen P ^a   Phumoonna, Tongted ^a   Poon, Rachael ^a   Adams, Vicki ^a   Vedantam, Gayatri ^b,c   Johnson, Stuart ^b,c   Gerding, Dale N ^b,c   Rood, Julian I ^a  

^a MONASH UNIVERSITY   (Australia)

^b HINES VA HOSPITAL   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B;

AMINO ACID; ANTIBIOTICS; CELL ORGANELLE; DIARRHEAL DISEASE; GLUCOSE; INFECTIOUS DISEASE; MORTALITY; TOXIN; VIRULENCE;

ANIMAL CELL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERO CELL;

ANIMALS; BACTERIAL ADHESION; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL LINE; CLOSTRIDIUM DIFFICILE; CRICETINAE; DISEASE MODELS, ANIMAL; ENTEROTOXINS; HUMANS; MUTATION; VIRULENCE;

ANIMALIA; CLOSTRIDIUM DIFFICILE; CRICETINAE;

EID: 67349114409     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature07822     Document Type: Article

References (38)

1. McDonald, L. C. et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353, 2433-2441 (2005).
2. Warny, M. et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366, 1079-1084 (2005).
3. Bartlett, J. G. et al. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 75, 778-782 (1978).
4. Bartlett, J. G. Antibiotic-associated diarrhea. N. Engl. J. Med. 346, 334-339 (2002).
5. Redelings, M. D., Sorvillo, F. & Mascola, L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg. Infect. Dis. 13, 1417-1419 (2007).
6. O'Brien, J. A., Lahue, B. J., Caro, J. J. & Davidson, D. M. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect. Control Hosp. Epidemiol. 28, 1219-1227 (2007).
7. von Eichel-Streiber, C. et al. Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol. Gen. Genet. 233, 260-268 (1992).
8. Just, I. & Gerhard, R. Large clostridial cytotoxins. Rev. Physiol. Biochem. Pharmacol. 152, 23-47 (2004).
9. Voth, D. E. & Ballard, J. D. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18, 247-263 (2005).
10. Jank, T. & Aktories, K. Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol. 16, 222-229 (2008).
11. Just, I. et al. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375, 500-503 (1995).
12. Lyerly, D. M., Saum, K. E., MacDonald, D. K. & Wilkins, T. D. Effects of Clostridium difficile toxins given intragastrically to animals. Infect. Immun. 47, 349-352 (1985).
13. O'Connor, J. R. et al. Construction and analysis of chromosomal Clostridium difficile mutants. Mol. Microbiol. 61, 1335-1351 (2006).
14. Heap, J. T. et al. The ClosTron: a universal gene knock-out system for the genus Clostridium. J. Microbiol. Methods 70, 452-464 (2007).
15. Dineen, S., Villapakkam, A. C., Nordman, J. T. & Sonenshein, A. L. Repression of Clostridium difficile toxin gene expression by CodY. Mol. Microbiol. 66, 206-219 (2007).
16. Mani, N. et al. Environmental response and autoregulation of Clostridium difficile TxeR, a sigma factor for toxin gene expression. J. Bacteriol. 184, 5971-5978 (2002).
17. Matamouros, S., England, P. & Dupuy, B. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol. Microbiol. 64, 1274-1288 (2007).
18. Schirmer, J. & Aktories, K. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins. Biochim. Biophys. Acta 1673, 66-74 (2004).
19. Torres, J., Camorlinga-Ponce, M. & Munoz, O. Sensitivity in culture of epithelial cells from rhesus monkey kidney and human colon carcinoma to toxins A and B from Clostridium difficile. Toxicon 30, 419-426 (1992).
20. Giesemann, T. et al. Cholesterol-dependent pore formation of Clostridium difficile toxin A. J. Biol. Chem. 281, 10808-10815 (2006).
21. Burger, S. et al. Expression of recombinant Clostridium difficile toxin A using the Bacillus megaterium system. Biochem. Biophys. Res. Commun. 307, 584-588 (2003).
22. Tang-Feldman, Y. J. et al. One-step cloning and expression of Clostridium difficile toxin B gene (tcdB). Mol. Cell. Probes 16, 179-183 (2002).
23. Sambol, S. P. et al. Infection of hamsters with epidemiologically important strains of Clostridium difficile. J. Infect. Dis. 183, 1760-1766 (2001).
24. Kim, P. H., Iaconis, J. P. & Rolfe, R. D. Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters. Infect. Immun. 55, 2984-2992 (1987).
25. Du, T. & Alfa, M. J. Translocation of Clostridium difficile toxin B across polarized Caco-2 cell monolayers is enhanced by toxin A. Can. J. Infect. Dis. 15, 83-88 (2004).
26. Drudy, D., Fanning, S. & Kyne, L. Toxin A-negative, toxin B-positive Clostridium difficile. Int. J. Infect. Dis. 11, 5-10 (2007).
27. Johnson, S. et al. Fatal pseudomembranous colitis associated with a variant Clostridium difficile strain not detected by toxin A immunoassay. Ann. Intern. Med. 135, 434-438 (2001).
28. Benson, L., Song, X., Campos, J. & Singh, N. Changing epidemiology of Clostridium difficile-associated disease in children. Infect. Control Hosp. Epidemiol. 28, 1233-1235 (2007).
29. Smith, C. J., Markowitz, S. M. & Macrina, F. L. Transferable tetracycline resistance in Clostridium difficile. Antimicrob. Agents Chemother. 19, 997-1003 (1981).
30. Simon, R., Priefer, U. & Puhler, A. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Bio/Technology 1, 784-790 (1983).
31. Miller, J. H. Experiments in Molecular Genetics (Cold Spring Harbor Laboratory, 1972).
32. Inoue, H., Nojima, H. & Okayama, H. High efficiency transformation of Escherichia coli with plasmids. Gene 96, 23-28 (1990).
33. Sambrook, J. & Russell, D. W. Molecular Cloning: a Laboratory Manual (Cold Spring Harbor Laboratory Press, 2001).
34. Carter, G. P. et al. Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J. Bacteriol. 189, 7290-7301 (2007).
35. Lyras, D. & Rood, J. I. Conjugative transfer of RP4-oriT shuttle vectors from Escherichia coli to Clostridium perfringens. Plasmid 39, 160-164 (1998).
36. Lyras, D. & Rood, J. Transposition of Tn4451 and Tn4453 involves a circular intermediate that forms a promoter for the large resolvase, TnpX. Mol. Microbiol. 38, 588-601 (2000).
37. Razaq, N. et al. Infection of hamsters with historical and epidemic BI types of Clostridium difficile. J. Infect. Dis. 196, 1813-1819 (2007).
38. Clabots, C. R. et al. Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J. Clin. Microbiol. 31, 1870-1875 (1993).